TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) — WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally-licensed producer (LP) and distributor of medical cannabis, is pleased to announce that on December 1, 2017 the Company secured its cannabis oil sales license from Health Canada. This is an amendment to the oil production license obtained in June 2017, and enables WeedMD to begin selling cannabis oil. The Company has developed two distinct cannabis oil brands. The first, AxisTM by WeedMD, has been specifically formulated for the seniors’ market, including long-term care and assisted living, while the second, EntourageTM by WeedMD, has been created to appeal to the general patient population under the Access to Cannabis for Medical Purposes Regulations (ACMPR). The Company plans to make its cannabis oil available for sale in early 2018.
“After receiving our license to produce cannabis oil just over five months ago, we are